LIPELLA PHARMACEUTICALS INC (LIPO)

US53630L1008 - Common Stock

0.3902  -0.02 (-3.84%)

After market: 0.4006 +0.01 (+2.67%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
259.35K
-73.03%		184.16K
-28.99%		449.62K
144.15%		287.64K
-36.03%
EBITDA
YoY % growth
N/AN/A-4.744MN/A
EBIT
YoY % growth
-1.916M
-3,268.79%		-2.59M
-35.17%		-4.746M
-83.26%		-4.669M
1.63%
Operating Margin
-738.70%-1,406.23%-1,055.55%-1,623.05%
EPS
YoY % growth
N/AN/AN/A-0.56

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24
EPS
Q2Q % growth		-0.12
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-1.182M
12.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 136.43K
27.89%		%
Q1 2024
Q2Q % growth		 145.88K
23.57%		%
Q4 2023
Q2Q % growth		 120.84K
-19.98%		%
Q3 2023
Q2Q % growth		 104.05K
213.88%		%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -103.7% -103.7%
RevenueN/A N/A 93.15% 93.15%